New 5-aminolevulinic acid prodrugs for use in photodynamic therapy and photodynamic diagnosis

Details for Australian Patent Application No. 2009286182 (hide)

Owner Swedish Pharma AB

Inventors Eriksson, Leif A.; Lofgren, Lennart

Agent Griffith Hack

Pub. Number AU-A-2009286182

PCT Pub. Number WO2010/024775

Priority 0801887-1 01.09.08 SE; 61/136,369 02.09.08 US

Filing date 1 September 2009

Wipo publication date 4 March 2010

International Classifications

C07C 251/38 (2006.01) Compounds containing nitrogen atoms doubly- bound to a carbon skeleton

A61K 31/197 (2006.01)

A61K 31/325 (2006.01) - Carbamic acids

A61P 35/00 (2006.01) Antineoplastic agents

C07C 271/22 (2006.01) Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups

Event Publications

21 April 2011 PCT application entered the National Phase

  PCT publication WO2010/024775 Priority application(s): WO2010/024775

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009286183-ANLN protein as an endocrine treatment predictive factor

2009286177-Wet granulation system comprising at least one ultrasonic nozzle